FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4375951434> ?p ?o ?g. }

• W4375951434 endingPage "1098" @default.
• W4375951434 startingPage "1089" @default.
• W4375951434 abstract "Background Transrectal ultrasonography (TRUS)/magnetic resonance imaging (MRI) fusion-guided biopsy has a high clinical application value. However, this technique has some limitations, which limit its use in routine clinical practice. Therefore, the selection of suitable proatate lesions for this technique is worthy of our attention. Synthetic MRI (SyMRI) is capable of quantifying multiple relaxation parameters, which might have potential value in preprocedural evaluation for TRUS/MRI fusion-guided biopsy of the prostate. The aim of our study is to examine the value of SyMRI quantitative parameters in preprocedural evaluation for TRUS/MRI fusion-guided biopsy of the prostate. Methods We prospectively selected 148 lesions in 137 patients who underwent prostate biopsy in our hospital. Next, 2–4 needles of TRUS/MRI fusion-guided biopsy combined with 10 needles of system biopsy (SB) were used as the protocol for prostate biopsy. Before biopsy, the MAGiC sequences of the MRI images of the enrolled patients underwent post-processing, and the longitudinal relaxation time (T1), transverse relaxation time (T2), and proton density (PD) were extracted. The biopsy pathology results were used as a gold standard to compare the differences in SyMRI quantitative parameters between benign and malignant prostate lesions in the peripheral and transitional zones. The receiver operating characteristic (ROC) curves were plotted to confirm the optimal SyMRI quantitative parameter for prostate lesion benignancy/malignancy performance, and the cutoff values of these parameters were used for grouping the lesions. The single-needle biopsy prostate cancer (PCa)-positivity rates (number of positive biopsy needles/total biopsy needles) and PCa overall detection rates by TRUS/MRI fusion-guided biopsy and SB were compared in different subgroups. Results The T1 and T2 values can determine the benignancy/malignancy of prostate transition lesions(p < 0.01), and the T2 value has a greater diagnostic performance (p = 0.0376). The T2 value can determine the benignancy/malignancy of prostate peripheral lesions. The optimal diagnostic cutoff values for T2 were 77 and 81 ms, respectively. The single-needle PCa positivity rate of TRUS/MRI fusion-guided biopsy was higher than SB for any prostate lesions in different subgroups (p < 0.01). However, only in the subgroup of transition zone lesions with T2 ≤ 77 ms, the PCa overall detection rate of TRUS/MRI fusion-guided biopsy was significantly higher than that of SB (p = 0.031). Conclusion SyMRI-T2 value can provide a theoretical basis for the selection of suitable lesions for TRUS/MRI fusion-guided biopsy." @default.
• W4375951434 created "2023-05-10" @default.
• W4375951434 creator A5008636823 @default.
• W4375951434 creator A5014481721 @default.
• W4375951434 creator A5030752607 @default.
• W4375951434 creator A5039005708 @default.
• W4375951434 creator A5058687102 @default.
• W4375951434 creator A5059751095 @default.
• W4375951434 creator A5071762492 @default.
• W4375951434 creator A5073216396 @default.
• W4375951434 creator A5083896582 @default.
• W4375951434 creator A5086257868 @default.
• W4375951434 date "2023-05-08" @default.
• W4375951434 modified "2023-09-25" @default.
• W4375951434 title "Value of synthetic MRI quantitative parameters in preprocedural evaluation for TRUS/MRI fusion‐guided biopsy of the prostate" @default.
• W4375951434 cites W1827911007 @default.
• W4375951434 cites W2056153636 @default.
• W4375951434 cites W2129589381 @default.
• W4375951434 cites W2164191119 @default.
• W4375951434 cites W2517261003 @default.
• W4375951434 cites W2579950569 @default.
• W4375951434 cites W2592511109 @default.
• W4375951434 cites W2608930246 @default.
• W4375951434 cites W2730767595 @default.
• W4375951434 cites W2810957340 @default.
• W4375951434 cites W2898847243 @default.
• W4375951434 cites W2922071185 @default.
• W4375951434 cites W2925208616 @default.
• W4375951434 cites W2925305319 @default.
• W4375951434 cites W2943606118 @default.
• W4375951434 cites W2957236657 @default.
• W4375951434 cites W2986384443 @default.
• W4375951434 cites W2990147117 @default.
• W4375951434 cites W3004708149 @default.
• W4375951434 cites W3119005666 @default.
• W4375951434 cites W3137473894 @default.
• W4375951434 cites W3164057109 @default.
• W4375951434 cites W4206994518 @default.
• W4375951434 doi "https://doi.org/10.1002/pros.24550" @default.
• W4375951434 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37157155" @default.
• W4375951434 hasPublicationYear "2023" @default.
• W4375951434 type Work @default.
• W4375951434 citedByCount "0" @default.
• W4375951434 crossrefType "journal-article" @default.
• W4375951434 hasAuthorship W4375951434A5008636823 @default.
• W4375951434 hasAuthorship W4375951434A5014481721 @default.
• W4375951434 hasAuthorship W4375951434A5030752607 @default.
• W4375951434 hasAuthorship W4375951434A5039005708 @default.
• W4375951434 hasAuthorship W4375951434A5058687102 @default.
• W4375951434 hasAuthorship W4375951434A5059751095 @default.
• W4375951434 hasAuthorship W4375951434A5071762492 @default.
• W4375951434 hasAuthorship W4375951434A5073216396 @default.
• W4375951434 hasAuthorship W4375951434A5083896582 @default.
• W4375951434 hasAuthorship W4375951434A5086257868 @default.
• W4375951434 hasConcept C121608353 @default.
• W4375951434 hasConcept C126322002 @default.
• W4375951434 hasConcept C126838900 @default.
• W4375951434 hasConcept C142724271 @default.
• W4375951434 hasConcept C143409427 @default.
• W4375951434 hasConcept C2775934546 @default.
• W4375951434 hasConcept C2776235491 @default.
• W4375951434 hasConcept C2779399171 @default.
• W4375951434 hasConcept C2780002838 @default.
• W4375951434 hasConcept C2780192828 @default.
• W4375951434 hasConcept C2781217009 @default.
• W4375951434 hasConcept C2989005 @default.
• W4375951434 hasConcept C40993552 @default.
• W4375951434 hasConcept C58471807 @default.
• W4375951434 hasConcept C71924100 @default.
• W4375951434 hasConceptScore W4375951434C121608353 @default.
• W4375951434 hasConceptScore W4375951434C126322002 @default.
• W4375951434 hasConceptScore W4375951434C126838900 @default.
• W4375951434 hasConceptScore W4375951434C142724271 @default.
• W4375951434 hasConceptScore W4375951434C143409427 @default.
• W4375951434 hasConceptScore W4375951434C2775934546 @default.
• W4375951434 hasConceptScore W4375951434C2776235491 @default.
• W4375951434 hasConceptScore W4375951434C2779399171 @default.
• W4375951434 hasConceptScore W4375951434C2780002838 @default.
• W4375951434 hasConceptScore W4375951434C2780192828 @default.
• W4375951434 hasConceptScore W4375951434C2781217009 @default.
• W4375951434 hasConceptScore W4375951434C2989005 @default.
• W4375951434 hasConceptScore W4375951434C40993552 @default.
• W4375951434 hasConceptScore W4375951434C58471807 @default.
• W4375951434 hasConceptScore W4375951434C71924100 @default.
• W4375951434 hasIssue "11" @default.
• W4375951434 hasLocation W43759514341 @default.
• W4375951434 hasLocation W43759514342 @default.
• W4375951434 hasOpenAccess W4375951434 @default.
• W4375951434 hasPrimaryLocation W43759514341 @default.
• W4375951434 hasRelatedWork W2032122689 @default.
• W4375951434 hasRelatedWork W2046981875 @default.
• W4375951434 hasRelatedWork W2052079328 @default.
• W4375951434 hasRelatedWork W2144359362 @default.
• W4375951434 hasRelatedWork W2153860297 @default.
• W4375951434 hasRelatedWork W2376019423 @default.
• W4375951434 hasRelatedWork W2390982334 @default.
• W4375951434 hasRelatedWork W2404675558 @default.
• W4375951434 hasRelatedWork W2406073138 @default.

• next